NIH-funded research NIH-funded research

Preparing for and responding to pandemics through advanced research

Official title: UofL RBL Pandemic Preparedness and Response Integrated Research Core

Funded at University of Louisville · NIH-10910209 · Data updated 2026-11-12

This study is all about getting ready for future pandemics by looking at how certain germs affect older people and those with chronic illnesses, while also considering the role of environmental toxins, and it's designed for researchers and health experts who want to improve our response to these health threats.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Louisville
NIH-funded
Lab location1 site (Louisville, United States)
Project startAugust 18, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$1,590,949
NIH project number5UC7AI180309-02
Project IDNIH-10910209 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit include individuals affected by chronic diseases or those at risk of infections from serious pathogens.

Less likely to help

Patients with acute infections not related to Risk Group 3 pathogens may not receive benefit from this research.

What this research studies

This research focuses on enhancing pandemic preparedness by supporting studies related to Risk Group 3 pathogens at the University of Louisville's Regional Biocontainment Laboratory. It provides scientific expertise for study design, execution of laboratory and animal studies, and data analysis. The core aims to refine infection models and investigate how aging and chronic diseases affect responses to these pathogens, as well as the impact of environmental toxins. This integrated approach allows for collaboration among various academic and industrial partners to improve public health responses.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for managing and preventing pandemics, ultimately saving lives.

How similar studies have gone: Previous research has shown success in developing effective responses to pandemics using similar integrated approaches.

Where this research is happening

  • University of Louisville
    Louisville, United States
    Active

Researchers

  • Principal investigator: Palmer, Kenneth E — University of Louisville
  • Study coordinator: Palmer, Kenneth E

Related research

Other NIH-funded projects on the same topics.

  • Gastric rhythm map to understand stomach problems using a new noninvasive tool

    A new noninvasive body surface mapping method is being tested to see if abnormal stomach electrical rhythms explain chronic stomach problems like functional dyspepsia and persistent nausea.

    NIH research University of Louisville · Louisville, United States · NIH-11611507

  • Novel antivirals for alphavirus arthritis

    A research team is refining a promising antiviral compound to treat alphavirus infections that cause arthritis, with a focus on Chikungunya and related viruses.

    NIH research University of Louisville · Louisville, United States · NIH-11609180

  • Linking heavy metal exposure to a tougher breast cancer type (TNBC)

    Aimed at understanding how heavy metals like cadmium might trigger a dangerous breast cancer type (TNBC) in people, especially those with BRCA1 risk, to identify possible future treatment strategies.

    NIH research University of Louisville · Louisville, United States · NIH-11567535

  • Cardiac safety of flavored e-cigarette aerosols in adults

    A pharmacist or clinician would test how inhaling flavored e-cigarette aerosols affects heart rhythm in adults to see if flavors raise the risk of heart problems.

    NIH research University of Louisville · Louisville, United States · NIH-11541950

  • Biomedical Research Facilities to Expand Precision Medicine in Kentucky

    A large NIH grant aims to renovate and expand a shared precision medicine center in Kentucky to speed up research that could improve health for people in Appalachia and surrounding areas.

    NIH research University of Louisville · Louisville, United States · NIH-11523167

  • Rac-enhanced CAR-Macrophages against TNBC

    A new cell therapy approach uses engineered macrophages with a CAR and Rac2 activation to target and kill triple-negative breast cancer cells expressing CSPG4.

    NIH research University of Louisville · Louisville, United States · NIH-11520503

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.